MedTrace Logo

Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG

NCT05161065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-10-03

No results posted yet for this study

Summary

The WatchQT study will compare the performance of a smartwatch combined with Cardiologs ECG AI Analysis system in monitoring corrected QT (QTc) intervals with that measured on a manually read 12-lead ECG in subjects with Normal Sinus Rhythm (NSR) during antiarrhythmic drug (AAD) initiation and follow-up at the hospital.

Conditions

Interventions

DEVICE

Cardiologs

Apple Watch recordings interpreted by Cardiologs AI done simultaneously with each 12-lead ECG

Sponsors & Collaborators

  • Cardiologs Technologies

    lead INDUSTRY

Principal Investigators

  • Jagmeet Singh, MD ScM DPhil · Massachusetts General Hospital

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-12
Primary Completion
2023-02-28
Completion
2023-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05161065 on ClinicalTrials.gov